Burning Rock Biotech Ltd
NASDAQ:BNR

Watchlist Manager
Burning Rock Biotech Ltd Logo
Burning Rock Biotech Ltd
NASDAQ:BNR
Watchlist
Price: 3.23 USD 4.19% Market Closed
Market Cap: 33.1m USD

Wall Street
Price Targets

BNR Price Targets Summary
Burning Rock Biotech Ltd

There are no price targets for BNR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Burning Rock Biotech Ltd Competitors:
Price Targets
002007
Hualan Biological Engineering Inc
22% Upside
GNFT
Genfit SA
147% Upside
688278
Xiamen Amoytop Biotech Co Ltd
41% Upside
CVAC
CureVac NV
52% Upside
1952
Everest Medicines Ltd
22% Upside
TSVT
2Seventy Bio Inc
2% Upside
301207
Hualan Biological Bacterin Inc
18% Upside
EXEL
Exelixis Inc
10% Downside

Revenue
Forecast

Revenue Estimate
Burning Rock Biotech Ltd

For the last 6 years the compound annual growth rate for Burning Rock Biotech Ltd's revenue is 16%. The projected CAGR for the next 2 years is 49%.

16%
Past Growth
49%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Burning Rock Biotech Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
55%
Average Beat

Net Income
Forecast

Net Income Estimate
Burning Rock Biotech Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
43%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BNR's stock price target?
Not Available

BNR doesn't have any price targets made by Wall Street professionals.

What is Burning Rock Biotech Ltd's Revenue forecast?
Projected CAGR
49%

For the last 6 years the compound annual growth rate for Burning Rock Biotech Ltd's revenue is 16%. The projected CAGR for the next 2 years is 49%.

Back to Top